Monashee Investment Management LLC Satsuma Pharmaceuticals, Inc. Transaction History

Monashee Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$4.54 - $7.17 $535,842 - $846,253	-118,027 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$4.8 - $7.25 $278,544 - $420,717	-58,030 Reduced 32.96%	118,027 $832,000
Q1 2021 May 14, 2021	BUY	$4.57 - $7.18 $804,580 - $1.26 Million	176,057 New	176,057 $1.04 Million
Q4 2019 Feb 12, 2020	SELL	$9.32 - $19.68 $582,500 - $1.23 Million	-62,500 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$14.98 - $16.9 $936,250 - $1.06 Million	62,500 New	62,500 $938,000

Ticker STSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,587,500
Description
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.